| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with lung adenocarcinoma: A radiologist’s perspective
|
Gorospe, Luis
|
|
2017
|
110 |
C |
p. 77-79
3 p.
|
artikel
|
| 2 |
Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women’s Health Initiative
|
Tao, Meng-Hua
|
|
2017
|
110 |
C |
p. 42-47
6 p.
|
artikel
|
| 3 |
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations
|
Shen, Yi-Cheng
|
|
2017
|
110 |
C |
p. 56-62
7 p.
|
artikel
|
| 4 |
Contents
|
|
|
2017
|
110 |
C |
p. iv-v
nvt p.
|
artikel
|
| 5 |
Cost-effectiveness analysis of additional bevacizumab to pemetrexed plus cisplatin for malignant pleural mesothelioma based on the MAPS trial
|
Zhan, Mei
|
|
2017
|
110 |
C |
p. 1-6
6 p.
|
artikel
|
| 6 |
De novo cystic brain lesions mimicking neurocysticercosis in ALK-positive lung cancer
|
Kim, Su-Hyun
|
|
2017
|
110 |
C |
p. 53-55
3 p.
|
artikel
|
| 7 |
DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel
|
Takamochi, Kazuya
|
|
2017
|
110 |
C |
p. 26-31
6 p.
|
artikel
|
| 8 |
Do protons have a role in the treatment of locally advanced NSCLC with radiotherapy?
|
McDonald, Fiona
|
|
2017
|
110 |
C |
p. 71-73
3 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2017
|
110 |
C |
p. iii-
1 p.
|
artikel
|
| 10 |
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer
|
Kobayashi-Watanabe, Naomi
|
|
2017
|
110 |
C |
p. 35-41
7 p.
|
artikel
|
| 11 |
GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis
|
Feng, Yanfen
|
|
2017
|
110 |
C |
p. 48-52
5 p.
|
artikel
|
| 12 |
Identification of a novel T1151K ALK mutation in a patient with ALK-rearranged NSCLC with prior exposure to crizotinib and ceritinib
|
Zhu, Viola W.
|
|
2017
|
110 |
C |
p. 32-34
3 p.
|
artikel
|
| 13 |
MYC expression correlates with PD-L1 expression in non-small cell lung cancer
|
Kim, Eun Young
|
|
2017
|
110 |
C |
p. 63-67
5 p.
|
artikel
|
| 14 |
Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy
|
Liao, Bin-Chi
|
|
2017
|
110 |
C |
p. 7-13
7 p.
|
artikel
|
| 15 |
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
|
Dickhoff, C.
|
|
2017
|
110 |
C |
p. 14-18
5 p.
|
artikel
|
| 16 |
Supraclavicular schwannoma mimicking a lymphadenopathy in a lung cancer patient: PET/CT findings
|
Gorospe, Luis
|
|
2017
|
110 |
C |
p. 74-76
3 p.
|
artikel
|
| 17 |
Thymic malignancies: Twisting between autoimmunity and immunotherapy
|
Girard, Nicolas
|
|
2017
|
110 |
C |
p. 68-70
3 p.
|
artikel
|
| 18 |
Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis
|
Sands, Jacob
|
|
2017
|
110 |
C |
p. 19-25
7 p.
|
artikel
|
Tijdschrift beschrijving